|
MBNL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.87949999996828E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.42790000046134E-07 |
| Normal-vs-Stage2 |
4.376800E-03 |
| Normal-vs-Stage3 |
1.435040E-01 |
| Normal-vs-Stage4 |
3.505200E-01 |
| Stage1-vs-Stage2 |
3.054000E-01 |
| Stage1-vs-Stage3 |
1.369980E-01 |
| Stage1-vs-Stage4 |
4.450600E-01 |
| Stage2-vs-Stage3 |
5.219400E-01 |
| Stage2-vs-Stage4 |
7.382600E-01 |
| Stage3-vs-Stage4 |
9.381400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.03929999994978E-06 |
| Normal-vs-AfricanAmerican |
4.23480000000254E-05 |
| Normal-vs-Asian |
9.332200E-01 |
| Caucasian-vs-AfricanAmerican |
9.642200E-01 |
| Caucasian-vs-Asian |
4.924600E-01 |
| AfricanAmerican-vs-Asian |
4.993200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.79129999511707E-08 |
| Normal-vs-Female |
1.185630E-01 |
| Male-vs-Female |
2.520400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.502800E-03 |
| Normal-vs-Extreme_Weight |
1.6530110613644E-12 |
| Normal-vs-Obese |
4.098700E-03 |
| Normal-vs-Extreme_Obese |
1.52293999999831E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.945500E-02 |
| Normal_Weight-vs-Obese |
5.463000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.356000E-02 |
| Extreme_Weight-vs-Obese |
1.423950E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.495400E-01 |
| Obese-vs-Extreme_Obese |
9.636000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.816950E-01 |
| Normal-vs-Age(41-60Yrs) |
1.804810E-03 |
| Normal-vs-Age(61-80Yrs) |
3.9497999981819E-08 |
| Normal-vs-Age(81-100Yrs) |
8.38430000000834E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.818600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.363600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.103600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.190400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.130990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.782200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.44070000041019E-07 |
| Normal-VS-Type2 PRCC |
9.94330000000376E-05 |
| Normal-VS-KIRP CIMP |
8.126000E-01 |
| Normal-VS-Unclassified PRCC |
5.193200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.897400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.400160E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.487400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.808830E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.365200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.007400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.58159999999563E-06 |
| Normal-vs-N1 |
1.381950E-01 |
| Normal-vs-N2 |
8.603200E-01 |
| N0-vs-N1 |
1.074760E-01 |
| N0-vs-N2 |
4.370600E-01 |
| N1-vs-N2 |
4.061800E-01 |
|
|
